GLIBA vs MGNI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
GLIBA exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the company maintains a strong liquidity position with a current ratio of 3.14 and trades at a discount to book value (P/B 0.85), these are offset by negative net profit margins (-29.54%) and stagnant revenue growth. A significant earnings miss of 66% in the most recent reported quarter further underscores the disconnect between current performance and the optimistic single-analyst target price of $68.00.
MGNI presents a compelling value opportunity, trading near its Graham Number ($11.74) and significantly below its growth-based intrinsic value ($28.02). While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, the company boasts impressive profitability margins and a P/E ratio (12.73) well below the sector average. Despite bearish technical trends and insider selling, the explosive earnings growth (230% YoY) and strong analyst consensus suggest a significant recovery potential.
Compare Another Pair
Related Comparisons
GLIBA vs MGNI: Head-to-Head Comparison
This page compares GCI Liberty, Inc. - Series A GC (GLIBA) and Magnite, Inc. (MGNI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.